Radiation Damage in Carnidazole: a Single Crystal EPR Study
Single crystals of hydrated and anhydrous carnidazole have been subjected to X-irradiation at 77 K and studied by EPR. The determination of the EPR tensors shows that NO2, sulfur-centered radicals as well as a radical pair can be generated from ...
Théo Berclaz +3 more
doaj +2 more sources
Evaluation of Lethal Effect of Pergularia Tomentosa and Priploca aphylla on Trichomonas Vaginalis In Vitro [PDF]
Background: Trichomonas vaginalis protozoan is one of the causes of human vaginitis. The selective medicine for treatment is metronidazole. However, it has some adverse outcomes including increasing drug resistance and having numerous side effects ...
Fouladvand, Morad Ali +2 more
core +1 more source
NITROIMIDAZOLES 111. [I]. SYNTHESIS, ANTIBACT - ERIAL AND ANTIFUNGAL ACTIVITY OF ZMETHYL - SU LFONYL -5 -(I-METHYL -5- NITRO-2- IMIDAZOLYL) 1,3,4-THIADIAZOLE [PDF]
2- Methylsulfonyl - 5- (1-methyl-5-nitro- 2 – imidazolyl ) 1,3,4 - thiadiazole ( 1 ) was prepared by twa independent routes.1) reaction of 1-methyl-2-formyl-5- nitroimidazole (3) with methyl hydrazinecarbodithioate gave the hydrazone 4.
doaj
Coincidence of bft and cfiA genes in a multi-resistant clinical isolate of Bacteroides fragilis [PDF]
Brazier Jon S. +4 more
core +1 more source
A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis. [PDF]
Graves KJ +5 more
europepmc +1 more source
Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity. [PDF]
Muzny CA, Van Gerwen OT, Kissinger P.
europepmc +1 more source
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. [PDF]
Aspatwar A +8 more
europepmc +1 more source
In vitro metabolic profile and drug-drug interaction assessment of secnidazole, a high-dose 5-nitroimidazole antibiotic for the treatment of bacterial vaginosis. [PDF]
Pentikis HS, Adetoro N, Kaufman G.
europepmc +1 more source
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy. [PDF]
Peerzada MN +6 more
europepmc +1 more source

